Literature
首页医源资料库在线期刊美国临床营养学杂志2002年75卷第3期

Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity

来源:《美国临床营养学杂志》
摘要:ABSTRACTBackground:ThefattyacidcontentandsaturationdegreeofthedietcanmodulateHDLcompositionandcholesterolefflux。Objective:Westudiedthemodificationsinplasmalipoproteinparticlesandserumcapacitytostimulatecholesteroleffluxinducedbydifferentfattyacids。Design:......

点击显示 收起

Maria Teresa Montoya, Amelia Porres, Sagrario Serrano, Jean Charles Fruchart, Pedro Mata, Juan Antonio Gómez Gerique and Graciela Rosa Castro

1 From the Fundación Jiménez Díaz, Servicio de Bioquímica Clínica, Madrid (MTM, AP, SS, PM, and JAGG), and the Institut Pasteur, INSERM Unité 325, Lille, France (JCF and GRC).

2 Supported by grants 93/0428 and 95/0838 from Fondo de Investigaciones Sanitarias (FIS).

3 Address reprint requests to JA Gómez Gerique, Servicio de Bioquímica Clínica, Fundación Jiménez Díaz, Avda, Reyes Católicos, 2 28040-Madrid, Spain. E-mail: jagomezg{at}meditex.es.


ABSTRACT  
Background: The fatty acid content and saturation degree of the diet can modulate HDL composition and cholesterol efflux.

Objective: We studied the modifications in plasma lipoprotein particles and serum capacity to stimulate cholesterol efflux induced by different fatty acids.

Design: Seventeen women and 24 men followed in the same sequence 4 diets containing 35% of total energy as fat. The saturated fat diet contained 17% palm oil; the monounsaturated fat diet, 20.9% olive oil; the n-6 polyunsaturated fat diet, 12.5% sunflower oil; and the n-3 polyunsaturated fat diet, sunflower oil supplemented with 4–4.5 g fish oil/d. Each phase lasted 4–5 wk.

Results: In both sexes, apolipoprotein (apo) A-I concentrations were significantly lower with unsaturated fat diets than with the saturated fat diet, but concentrations of lipoproteins containing only apo A-I (Lp A-I) were lower only in the men. Concentrations of lipoproteins containing both apo A-I and apo A-II (Lp A-I:A-II) were lower with both polyunsaturated fat diets in the women but significantly higher in the men. Lp E concentrations were significantly higher with the 2 polyunsaturated fat diets. Lp E non–B particle concentrations were not modified in the men but were significantly higher in the women in both polyunsaturated fat phases. Lp C-III concentrations were higher with the saturated fat diet only in the men. The serum samples taken after the n-3 polyunsaturated fat phase were the most efficient for extracting cellular cholesterol in both sexes.

Conclusions: The monounsaturated and polyunsaturated fat diets were healthier, producing a better lipid profile. The n-3 polyunsaturated fat diet increased the capacity of serum to promote the efflux of cholesterol from cells in culture.

Key Words: Diet • fatty acid • lipid • lipoprotein particle • cholesterol efflux • reverse cholesterol transport • HDL • LDL • saturated fat • polyunsaturated fat • monounsaturated fat


INTRODUCTION  
The incidence of cardiovascular disease (CVD), the main cause of death and morbidity in developed countries (1), is closely related to diet, mainly to fat composition. The type of fat in the diet can modify the lipid profile, which is directly related to the growth of atheroma plaque (2, 3). In Spain, the mortality rate due to this disease is relatively low compared with that in other developed countries (4, 5). This finding could be explained by 2 facts: the Spanish diet is rich in vegetables, fruit, fish, and oils containing monounsaturated fatty acids (MUFAs), a regimen considered favorable for cardiovascular health (6), and Spaniards have elevated plasma concentrations of HDL (7).

However, in the dietetic studies performed until now, the results regarding changes in HDL with the administration of monounsaturated fats are controversial (2, 8, 9). Several epidemiologic studies showed an inverse correlation between serum concentrations of HDL cholesterol and the risk of CVD (10). This favorable role of HDL is mainly due to its participation in metabolic reverse cholesterol transport, which allows the liver to eliminate excess cholesterol in peripheral tissues (11). Reverse cholesterol transport consists of several steps: efflux of cholesterol from cell membranes to acceptor particles, esterification of cellular cholesterol by phosphatidylcholine-sterol O-acyltransferase (lecithin-cholesterol acyltransferase), transfer of cholesterol esters to low-density or very-low-density particles with the contribution of the cholesterol ester transfer protein, and, finally, delivery of cholesterol esters to the liver (12).

The HDL fractions obtained by ultracentrifugation techniques (13) are a group of heterogeneous particles. Particles more homogeneous in structure and function are isolated according to apolipoprotein (apo) composition (14, 15). Particles that contain only apo A-I are termed Lp A-I; those containing apo A-I and apo A-II are termed Lp A-I:A-II. Several studies have shown important metabolic differences between these 2 kinds of particles (16–21). It is accepted that Lp A-I constitutes the antiatherogenic fraction of HDL, and serum concentrations of Lp A-I and Lp A-I:A-II are defined as a new CVD risk marker (22, 23).

Other minor particles contain apo C-III and apo E (Lp C-III non-B and Lp E non-B). The importance of these particles, the role of which is still not completely elucidated, has been suggested by data from case-control studies that implicated apo C-III and apo E ratios (eg, Lp C-III non-B/Lp C-III:B and Lp E non-B/Lp E:B) as potential CVD risk markers (24, 25). Another type of particle containing apo E as the only apolipoprotein (Lp E) has been proposed as an element responsible for promoting cholesterol efflux, mainly when there is a shortage of the main acceptor particles (26).

It has been suggested that eating foods rich in fatty acids of different saturation grades modifies the composition and structure of HDL by changing the acyl chain content of HDL phospholipids (27). Furthermore, several studies have confirmed that the concentration of Lp A-I and Lp A-I:AII particles changes when the fatty acid composition of the diet is modified (28, 29). On the other hand, the results of several studies of the effect of dietary fatty acid composition on serum capacity to promote cellular cholesterol efflux are still controversial (30–33).

In the present study, a long-term diet rich in vegetables, fruit, fish, and oils was administered to a healthy population. Different diets were created by varying the fatty acid saturation grade to study the effect on the plasma lipid and lipoprotein particle profile. This report is a post hoc analysis, and we describe the changes in the sera capacity to induce efflux of cholesterol from cells in culture.


SUBJECTS AND METHODS  
The study design, population, and diets were described in previous publications (34).

Study population
Forty-one healthy volunteers gave their written consent to take part in the study. The population comprised 17 nuns (10 postmenopausal) and 24 priests, with a mean (±SD) age of 45.8 ± 9.5 and 45.1 ± 16.2 y, respectively, and a body mass index (in kg/m2) of 24.8 ± 4.3 (26.6 ± 4.6 in the men, 23.1 ± 3 in the women). The subjects were free of clinical evidence of any chronic illness or obesity and had no family history of premature cardiovascular disease. Five of the men were smokers. The men had a baseline alcohol intake of <30 g/d. All of the women were nonsmokers consumed no alcohol. The diets were prepared and consumed in the subjects' communities. During the study period the subjects maintained their regular physical activity and lifestyle. This protocol was approved by the Human Studies Committee of the Jiménez Díaz Foundation.

Diets and study design
The participants were successively and in the same sequence fed 4 diets with the same total energy content: a saturated fatty acid (SFA) diet with a high palm oil content (17.3% of total energy); a MUFA diet with a predominance of oleic acid (18:1; 20.9% of total energy); an n-6 polyunsaturated fatty acid (PUFA) diet with a high percentage of sunflower oil (12.8% of total energy), containing mainly linoleic acid (18:2n-6); and another PUFA diet (n-3) enriched with fish oil (4–4.5 g/d; 1.6% of total energy). The energy composition of the diets was calculated by using food-composition tables. All menus were prepared with conventional food items. Special emphasis was placed on using foods that were not substantially different from those habitually consumed by the communities.

The total energy provided by each of the diets was adjusted to the participants' needs. Diet composition was similar: 15% of energy as protein, 50% of energy as carbohydrate, and 35% of energy as fat. The menus of each diet were repeated weekly. The proportional fatty acid content of the diets was adjusted by varying the culinary fat used. Butter and palm oil were used in the SFA diet, virgin olive oil in the MUFA diet, and sunflower oil in the PUFA diets. Changes were also made in foods with high fat contents (eg, milk, cheese, and nuts). During the n-3 PUFA period, fish oil was added daily to the sunflower oil.

Duplicate samples of all meals from randomly selected individuals (one man and one woman) were collected every day during 1 wk of each diet phase and stored at –20°C (Table 1). The fatty acid composition of the dietary oils used in this study was determined by capillary gas-liquid chromatography at the Food Analysis Laboratory of the Spanish Ministry of Agriculture (35). Palm oil consisted mainly of (% by wt) 37% palmitic acid (16:0), 43.6% oleic acid, and 11.7% linoleic acid. The major fatty acids in olive oil were palmitic acid (9.2%), oleic acid (80%), and linoleic acid (4.7%). The sunflower oil contained 6.8% palmitic acid, 29% oleic acid, and 56% linoleic acid.


View this table:
TABLE 1 . Mean daily intake of nutrients in each diet period1  
Each period lasted 5 wk, except the SFA diet phase, which lasted 4 wk. During the last 2 wk of each period, a physical examination was made of each subject during which blood pressure and weight were recorded. Physical activity and diet were recorded in a personal log, and blood was drawn to measure serum concentrations of the main indexes of lipid metabolism (lipoproteins and lipoprotein particles) and to measure cholesterol efflux.

Blood sampling and biochemical determinations
After the subjects had fasted for 12–14 h overnight, blood samples were obtained by venous puncture, collected in tubes (Vacutainer; Terumo Europe, Leuven, Belgium) containing a coagulation activator, and taken to the laboratory within 1 h. The tubes were centrifuged at 1500 x g for 15 min at room temperature, and the sera obtained were used for the following determinations.

Lipid and lipoprotein measurements were performed by using a combined ultracentrifugation-precipitation method recommended by the American Lipid Research Clinics (36). After precipitation-centrifugation of lipoproteins containing apo B with phosphotungstic acid and magnesium chloride (Boehringer Mannheim, Mannheim, Germany), cholesterol and phospholipid HDL were analyzed (37). Lipids in total serum and in the fractions were measured by using automated enzymatic methods (38, 39) (CHOD-PAP and GPO-PAP; Boehringer Mannheim). Phospholipids (Wako Chemical GmbH, Neuss, Germany) were measured in an RA-XT 100 autoanalyzer (Technicon, Tarrytown, NY), modifying the sample-reagent relation for each lipoprotein fraction to obtain good photometric accuracy. Apo B and A-I concentrations were measured by immunoturbidimetric methods (Boehringer Mannheim).

In all determinations the intra- and interassay CVs were always <5%. To confirm diet compliance, the fatty acid composition of the cholesterol ester and phospholipid fractions of plasma LDL was assessed at the end of each period by using thin-layer chromatography (40).

The serum concentration of lipoprotein particles was measured by using electroimmunodiffusion in agarose gels (Hydragel; Sebia, Issy-les-Moulineaux, France) (25, 41, 42) containing the corresponding monospecific antibody. Apo A-I, apo B, Lp A-I, Lp C-III, and Lp E were quantified in total sera, and Lp E non-B and Lp C-III non-B concentrations were quantified after precipitation of lipoproteins containing apo B. The Lp A-I:A-II concentration was calculated by subtracting the Lp A-I concentration from apo A-I (measured by using electroimmunodiffusion).

Cell culture, lipid radiolabeling, and efflux assay
Cellular cholesterol efflux was determined by using rat Fu5AH hepatoma cells, following the procedure previously described by De la Llera Moya et al (43). Briefly, the cells were maintained in MEM (Gibco BRL, Gaithersburg, MD) supplemented with 5% calf serum (Gibco BRL). Fu5AH cells (40–50 x 106 cells/L) were plated on 3.5-cm multiwell plates (Linbro; Polylabo, Strasbourg, France). Two days after plating, cellular cholesterol was labeled during a 48-h incubation with [3H]cholesterol (NEN; Perkin-Elmer Life Sciences, Brussels) at a conentration of 37 kBq/well. To allow equilibration of the label, the cells were rinsed and incubated for 24 h in MEM containing 0.5% bovine serum albumin (Sigma-Aldrich, St Louis). To measure cholesterol efflux, the cells were washed with phosphate-buffered saline and incubated at 37°C for 4 h, with the serum from each subject diluted to 2.5% in MEM. At the end of the efflux period, the medium was removed and centrifuged. Cell monolayers were washed 3 times with phosphate-buffered saline and harvested with 0.5 mL 0.1 mol NaOH/L. Finally, radioactivity was measured in both medium and cells, allowing the total radioactivity content in each well to be determined. Cholesterol efflux, expressed as a percentage, was calculated as the amount of label recovered in the medium divided by the total label in each well. Three wells of cells were incubated with 50 g HDL3/L as a positive control and another 3 with MEM as a negative control for each assay. The same HDL pool was used in all experiments for method standardization, and the mean efflux produced was 20 ± 0.9%.

Statistical analyses
Statistical analyses were performed with the use of the SAS statistical software (version 6.12; SAS Institute, Inc, Cary, NC). To investigate whether the changes observed with the different diets were dependent on sex, we initially performed a two-way analysis of variance for the main variable (cholesterol efflux), with the use of diet as a fixed effect and subject as a random effect and including a fixed sex effect and fixed sex-by-diet interaction (nesting the random subject effect within sex). Because in this analysis we obtained a strong sex-by-diet interaction (P < 0.0001), the analyses of the different variables related to efflux were performed for each sex independently, by using a two-way analysis of variance with diet as a fixed effect and subject as a random effect and comparing means after each diet by using Tukey's test in the model.

For a multiple regression analysis with the change in efflux as a dependent variable and the changes in lipid and lipoprotein particle variables as independent variables, we first ran a model including both sexes and tested for interactions between sex and the independent (predictor) variables. Because the results of this analysis showed no significant sex-by-treatment interaction, we performed only one multiple regression analysis, including both sexes.


RESULTS  
Diet composition and compliance
Diet composition, fatty acid profile, and cholesterol content data are shown in Table 1. The protein, carbohydrate, and fat contents of the 4 diets were nearly identical.

The fatty acid composition of the cholesterol ester and the phospholipid fractions of plasma LDL was assessed at the end of each period to confirm diet compliance. The results of this analysis are shown in Table 2. The palmitic acid content of both fractions was slightly but significantly higher after consumption of the SFA diet than after the 3 other diets. With the MUFA diet, the oleic acid content was significantly higher than with the other diets. During both PUFA diet periods, the linoleic acid content was significantly higher than during the SFA and MUFA phases; in addition, the long-chain PUFA content [eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)] was significantly higher after the n-3 PUFA diet than after the 3 other diets. Calculated mean body mass index was 24.6 ± 4.0 at the beginning of the study and remained constant throughout the experimental period.


View this table:
TABLE 2 . Effect of diets on fatty acid composition of serum phospholipids (PLs) and cholesterol esters (CEs)1  
Lipid and lipoprotein profile
Lipid and lipoprotein particle profiles (Table 3) were analyzed for each sex independently because the cholesterol efflux analysis showed a significant interaction between sex and the responses obtained in each diet period. Serum concentrations of total and LDL cholesterol were significantly lower in both sexes after all of the unsaturated fat diets than after the SFA diet. The addition of n-3 PUFA did not cause further significant modifications in the women, but the men had a lower LDL concentration with the n-3 PUFA diet than with the other diets. Triacylglycerol concentrations in the men were significantly lower with the PUFA diets than with the SFA and MUFA diets, but this result was seen only with the MUFA diet in the women. HDL-cholesterol concentrations did not differ among diet phases in either sex. In the women, but not in the men, the serum HDL phospholipid concentration was significantly lower after the n-3 PUFA diet than after the SFA diet.


View this table:
TABLE 3 . Lipid and lipoprotein distribution at the end of each diet period1  
Serum concentrations of apo A-I measured in the SFA phase were significantly higher than with the diets rich in MUFA or n-3 PUFA in the women; in the men, apo A-I concentrations were significantly lower only with the PUFA-rich diets. In the women, apo B concentrations were significantly lower with the diets rich in PUFA than with the other diets. In the men, apo B concentrations were lower with the MUFA and n-3 PUFA diets than with the other diets.

Cholesterol efflux
The serum capacity to induce cholesterol efflux was significantly higher during the n-3 PUFA phase than during the other phases in the men. In the women, this effect was observed during both PUFA phases (Figure 1).


View larger version (36K):
FIGURE 1. . Mean (±SEM) cellular cholesterol efflux from rat Fu5AH hepatoma cells treated with serum collected from 17 women and 24 men at the end of each diet phase: a saturated fatty acid (SFA) diet with a high palm oil content, a monounsaturated fatty acid (MUFA) diet with a high oleic acid content, an n-6 polyunsaturated fatty acid (PUFA) diet with a high percentage of sunflower oil, and an n-3 PUFA diet enriched with fish oil. The serum from each subject was diluted to 2.5% in MEM and the cells were incubated at 37°C for 4 h. Results of cholesterol efflux are percentage of total radioactivity. Bars within each sex with different superscript letters are significantly different, P < 0.05 (ANOVA with post hoc Tukey's test).

 
Lipoprotein particles
Serum Lp A-I concentrations were significantly lower with the MUFA and both PUFA diets than with the SFA diet, but only in the men (Table 4). As expected, in all phases the men's serum Lp A-I concentrations were lower than those observed in the women. Lp A-I:A-II concentrations were significantly lower with the 2 PUFA diets than with the SFA and MUFA diets in the women. In the men, Lp A-I:A-II concentrations were significantly higher with the n-6 PUFA diet than with all the other diets.


View this table:
TABLE 4 . Lipoprotein particle distribution at the end of each diet period1  
Serum Lp E concentrations were significantly higher during both PUFA phases than during the SFA and MUFA phases only in the women. Lp E non-B particle concentrations were not significantly different in the different phases in the men, but were higher in the women with the n-3 PUFA diet than with the other diets. Serum concentrations of both types of lipoprotein particles with apo C-III did not differ significantly by diet in the women; in the men they were higher with the SFA diet than with the n-3 PUFA diet (Lp C-III) and higher with the SFA diet than with the MUFA and n-6 PUFA (Lp C-III non-B).

There were no significant differences in the Lp E non-B/Lp E:B and Lp C-III non-B/Lp C-III:B coefficients by diet. In the multiple regression analysis, the variables associated with change in efflux were Lp A-I/Lp A-I:A-II and Lp A-I (Table 5). We found no significant correlations between the changes in the lipid composition of HDL and serum capacity to promote the efflux of cellular cholesterol.


View this table:
TABLE 5 . Differences in efflux between the saturated fatty acid–rich diet and the other diets for men and women combined1  

DISCUSSION  
The great differences in total cardioischemic mortality rates among developed countries whose citizens have similar lipid profiles and cholesterol concentrations indicate that other risk factors, such as diet, associated with the traditions of each country are decisive for CVD. The low mortality rate from CVD in Spain compared with that in other European countries is explained in part by the current Mediterranean diet, which contains large amounts of fruit, fish, and olive oil, foods able to reduce the effect of some risk factors (44). After the Seven Countries Study ascribed an important beneficial effect to the Mediterranean diet, it was proposed as a model (45, 46).

Despite several studies claiming to identify which diet is the healthiest and most advisable for the general population, the results are still controversial. Consumption of SFAs produces an increase in the total serum cholesterol concentration, mainly of the low-density atherogenic fraction; consumption of PUFAs decreases total serum cholesterol and LDL cholesterol concentrations in an efficient manner, although PUFAs also decrease the HDL-cholesterol fraction. Furthermore, MUFAs are responsible for a possible cardioprotective effect by diminishing LDL without modifying HDL cholesterol.

Because of the nature of the groups used, our study was designed as a parallel study (with every individual receiving the same diet at the same time), which may have allowed environmental factors to influence the results. Nevertheless, the data obtained in our study after administration of diets with different fatty acid saturations agree with those of the literature, showing that the lipoprotein profile after consumption of a diet with a high unsaturated fat content is hemodynamically healthier than profiles obtained after diets containing saturated fat because the unsaturated fat diet lowers total cholesterol and the atherogenic LDL fraction (8, 9). Unlike results in other studies, no substantial changes were seen in HDL-cholesterol concentrations in the men after a PUFA diet. However, apo A-I concentrations decreased with unsaturated fat (MUFA and PUFA) diets, agreeing with studies that showed an increase in the catabolism of these proteins with unsaturated fats (47). Thus, in the men, the serum Lp A-I particle concentrations were lower after consumption of diets with high MUFA and PUFA (n-3 and n-6) contents than after consumption of the SFA diet, as was observed in other studies (28, 29). In the women, the concentrations of HDL particles containing apo E (Lp E non-B) were higher with the n-3 PUFA diet.

The Lp E non-B/Lp E:B and Lp C-III non-B/Lp C-III:B coefficients, recently described as important CVD markers, differed significantly by diet in the present study, but when the mean ratio values were compared with those from other European populations (France and Northern Ireland) with a higher CVD mortality rate, we observed that the values for the Spanish population were higher (25).

In our study, the sera obtained after the administration of diets with a high n-6 PUFA content supplemented by fish revealed a major extraction of cell cholesterol in both sexes. Furthermore, in the women, the sera obtained after the consumption of diets with a high n-6 PUFA content also showed significantly more cholesterol efflux than did sera drawn during the SFA and MUFA phases. Although several studies (30–33, 48) recently investigated the effect of dietary fat type on cholesterol efflux, the results do not agree, and this important issue remains to be clarified.

Gillotte et al (32) performed a detailed study in primates of the possible effects of diets differing in degree of saturation. They concluded that all diets produce HDL of the same fluidity and size with an identical capacity to promote cellular cholesterol efflux. Besides using L-cell fibroblasts, this study also used the cell line used in our assays with similar incubation periods. The diets used in that study and our own are very similar, but the n-3 PUFA diet used by Gillotte et al contained a substantial percentage of SFA, which could have masked the effect found with our PUFA diet with a high fish content. The number of participants in our study was much higher (41 compared with 6 subjects), and this could explain the statistically significant differences we found.

Another study, performed in a different Spanish population (33) and using the same methodology and cell line, compared the effect of the low-fat diets recommended by the National Cholesterol Education Program (49) with a diet with a high MUFA content. There were no significant differences in cholesterol efflux, which could be attributed to the addition of MUFAs.

A study by Sakr et al (48), also using the same cell line but using postprandial plasma samples obtained after a single fat load, showed that a diet with a monounsaturated fat overload conferred a greater capacity to extract cellular cholesterol than did diets with a high SFA or PUFA content. Those results are probably the consequence of an acute effect, whereas our work shows the effect of modifying dietary fat saturation over a longer period.

In a study with a design quite similar to ours, Solá et al (30) previously showed that a diet with a high monounsaturated fat content produced smaller-sized HDL particles with greater fluidity and capacity to promote cholesterol efflux in fibroblasts than did the saturated and polyunsaturated fat diets. The study used the n-3 PUFA, SFA, and MUFA diets and showed that the n–3 PUFA diet has the lowest efficacy in cholesterol extraction. Although initially the results seemed contrary to ours, important differences could explain these discrepancies: this group performed 24-h incubations of fibroblast cultures with one isolated fraction of the serum, HDL3, thus excluding particles that play an important role in the exit of cellular cholesterol, pre-ß-HDL (16), Lp A-IV (50, 51), Lp E (23), and other plasma components that could modulate the action of these particles [eg, phosphatidylcholine-sterol O-acyltransferase and cholesteryl ester transfer protein (11, 52, 53)]. Our assay, which used a dilution of whole serum and an incubation time of 4 h, is much closer to physiologic conditions.

The same group used monocyte-derived macrophages and fibroblasts to compare the effect of a linoleic acid–rich diet with another diet enriched in oleic oil, without finding any differences in fluidity, size, or the cholesterol efflux capacity of the HDL3 obtained after both diets (31) In our results, the modifications in the cholesterol efflux capacity were not correlated with the modifications produced in HDL lipid concentrations but rather with the changes observed in some lipoprotein particle concentrations: Lp A-I and Lp A-I/Lp A-I:A-II. Our results suggest that a diet with an adequate ratio of monounsaturated (oleic acid) and polyunsaturated (especially fish oil) fatty acids and a low proportion of saturated fats is hemodynamically healthiest, producing a significant decrease in atherogenic lipoprotein particles. Furthermore, unsaturated fats induce an increase in serum capacity to promote cholesterol efflux from cells in culture, the first step in the antiatherogenic pathway of reverse cholesterol transport. Our study could explain the influence of diet on the complex mechanism of reverse cholesterol transport in lipid metabolism as well as its repercussions on inhibiting the formation or promoting the regression of atheromatous plaque.


ACKNOWLEDGMENTS  
We thank Alberto García (Logitest, Madrid) for his assistance in the statistical analysis, José R Garcia Hierro and the Analytical Laboratory of the Spanish Ministry of Agriculture for the analysis of the diets, Catherine de Geitere and Bernard Delfly for technical assistance, and the participants of the study for their enthusiasm.


REFERENCES  

  1. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988;41:155–78.
  2. Grundy SM, Denke MA. Dietary influence on serum lipids and lipoproteins. J Lipid Res 1990;31:1149–72.
  3. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992;12:911–9.
  4. Banegas JR, Rodríguez Artalejo F, Rodríguez Pérez P, Martín-Moreno JM, Villar F. Recent coronary heart disease mortality trends in Spain. Int J Epidemiol 1990;19:761–2.
  5. Banegas Banegas JR, Villar Alvarez F, Pérez de Andrés C, et al. An epidemiological study on cardiovascular risk factors in 35–64 year-old Spanish population. Rev Sanid Hig Publica (Madr) 1990;67:419–45.
  6. Mekki N, Dubois C, Charbonnier M, et al. Effects of lowering fat and increasing dietary fiber on fasting and posprandial plasma lipids in hypercholesterolemic subjects consuming a mixed Mediterranean-Western diet. Am J Clin Nutr 1997;66:1443–51.
  7. Gómez Gerique JA, Gutiérrez-Fuentes JA, Montoya MT, et al. Estudio DRECE. Dieta y riesgo de enfermedad cardiovascular en España. [Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovasular disease in Spain) study.] Med Clin (Barc) 1999;113:730–5 (in Spanish).
  8. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26:194–202.
  9. Mensink RP. Dietary monounsaturated fatty acids and serum lipoproteins level in healthy subjects. Atherosclerosis. 1994;110:565–8.
  10. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8–15.
  11. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995;36:211–28.
  12. Tall AR. An overview of reverse cholesterol transport. Eur Heart J 1998;19(suppl):A31–5.
  13. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345–53.
  14. Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. J Biol Chem 1984;259: 12201–9.
  15. Alaupovic P. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of apo-A and apo-B containing lipoprotein families. Prog Lipid Res 1991;30:105–38.
  16. Castro G. Fielding C. Early incorporation of cell-derived cholesterol into pre-beta-migrating high density lipoprotein. Biochemistry 1988;27:25–9.
  17. Rader DJ, Castro G, Zech LA, Fruchart JC, Brewer HB Jr. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles Lp A-I and LpAI:AII. J Lipid Res 1991;32:1849–59.
  18. Pieters MN, Castro G, Schouten D, Duchateau P, Fruchart JC, Van Berckel JC. Cholesterol esters selectively delivered in vivo by high density lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than LpAI:AII derived cholesterol esters. Biochem J 1993;292:819–23.
  19. Lagrost L, Persegol L, Lallemant C, Gambert P. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII. J Biol Chem 1994;269: 3189–97.
  20. Lagrost L, Dengremont C, Athias A, et al. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II. J Biol Chem 1995;270:13004–9.
  21. Rinninger F, Kaiser T, Greten H, Fruchart JC, Castro G. Selective uptake of cholesteryl esters from high density lipoprotein derived Lp A-I and LpAI:AII particles by hepatic cells in culture. Biochim Biophys Acta 1998;1393:277–91.
  22. Fruchart JC, Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification and clinical significance. Clin Chem 1992;38:793–7.
  23. O'Brien T, Nguyen TT, Hallaway BJ, et al. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease. Arterioscler Thromb Vasc Biol 1995;15:228–31.
  24. Parra HJ, Arveiler D, Evans A, et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: the ECTIM study. Arterioscler Thromb 1992;12:701–7.
  25. Luc G, Fievet C, Arveiler D, et al. Apolipoproteins C-III and E in apoB- and non-apoB- containing lipoproteins in two populations at contrasting risk for miocardial infarction: the ECTIM study. J Lipid Res 1996;37:508–17.
  26. Huang Y, Von Eckardstein A, Wu S, Maeda N, Assmann G. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci U S A 1994;91:1834–8.
  27. Solá R, Baudet MF, Motta C, Maille M, Boisnier C, Jacotot B. Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta 1990;1043:43–51.
  28. Fumeron F, Brigant L, Parra HJ, Bard JM, Fruchart JC, Apfelbaum M. Lowering of HDL2-cholesterol and lipoprotein A-I particle levels by increasing the ratio of polyunsaturated to saturated fatty acids. Am J Clin Nutr 1991;53:655–9.
  29. Fumeron F, Brigant L, Ollivier V, et al. n-3 Polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men. Am J Clin Nutr 1991;54:118–22.
  30. Solá R, Motta C, Maille M, et al. Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb 1993;13:958–66.
  31. Solá R, La Ville A, Richard JL, et al. Oleic-acid-rich diet protects against the oxidative modification of high density lipoprotein. Free Radic Biol Med 1997;6:1037–45.
  32. Gillotte KL, Lund-Katz S, de la Llera-Moya M, et al. Dietary modification of high density lipoprotein phospholipid and influence on cellular cholesterol efflux. J Lipid Res 1998;39:2065–75.
  33. Blanco-Molina A, Castro G, Martin-Escalante D, et al. Effects of different dietary cholesterol concentrations on lipoprotein plasma concentrations and on cholesterol efflux from Fu5AH cells. Am J Clin Nutr 1998;68:1028–33.
  34. Mata P, Alonso R, Lopez-Farre A, et al. Effect of dietary fat saturation on LDL oxidation and monocyte adhesion to human endothelial cells in vitro. Arterioscler Thromb Vasc Biol 1996;16:1347–55.
  35. Association of Official Analytical Chemists. Official method of analysis of the Association of Official Analytical Chemists. 15th ed. Arlington, VA: Association of Official Analytical Chemists, 1987.
  36. National Heart, Lung, and Blood Institute, National Institutes of Health. Manual of laboratory operations: lipid research clinics program. Vol 1. Lipid and lipoprotein analyses. Bethesda, MD: NIH, 1974. (DHEW publication 75-628.)
  37. Assmann G, Shrlewer H, Schmitz G. Quantification of high density lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem 1983;29:2026–30.
  38. Allain CC, Poons LS, Chang C, Richmond W, Fu PC. Enzimatic determination of total serum cholesterol. Clin Chem 1974;20:470–5.
  39. Buccolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 1973;19:476–82.
  40. Ruiz-Gutierrez V, Prada JL, Perez-Jimenez F. Determination of fatty acid and triacylglycerol composition of human very-low-density lipoproteins. J Chromatogr 1993;622:117–24.
  41. Laurell CB. Electroimmuno assay. Scand J Clin Lab Invest 1972; 29(suppl):21–37.
  42. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem 1990;36:1431–5.
  43. De la Llera Moya M, Atger V, Paul JL, et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification and transfer. Arterioscler Thromb 1994;14:1056–65.
  44. Serra-Majem L, Ribas L, Tresserras R, Ngo J, Salleras L. How could changes in diet explain changes in coronary heart disease mortality in Spain? The Spanish paradox. Am J Clin Nutr 1995; 61(suppl):1351S–9S.
  45. Keys A, Menotti A, Karvonen M. The diet and 25-year death rate in the Seven Countries Study. Am J Epidemiol 1995;124:903–15.
  46. Nestle M. Mediterranean diets: historical and research overview. Am J Clin Nutr 1995;61(suppl):1313S–20S.
  47. Brousseau ME, Schaefer EJ, Stucchi AF, et al. Diets enriched in unsaturated fatty acids enhance apolipoprotein A-I catabolism but do not affect either its production or hepatic mRNA abundance in cynomolgus monkeys. Atherosclerosis 1995;111:107–19.
  48. Sakr SW, Senault C, Vacher D, Fournier N, Girard-Globa A. Oleic acid-rich fats increase the capacity of postprandial serum to promote cholesterol efflux from Fu5AH cells. Biochim Biophys Acta 1996;1300:49–55.
  49. National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. Bethesda, MD: NIH, 1990.
  50. Duverger N, Ghalim N, Ailhaud G, Steinmetz A, Fruchart JC, Castro G. Characterization of apolipoprotein A-IV containing lipoprotein particles from human plasma and interstitial fluid. Arterioscler Thromb 1993;13:126–32.
  51. Duverger N, Ghalim N, Theret N, Fruchart JC, Castro G. Lipoproteins containing apolipoprotein A-IV: composition and relation to cholesterol esterification. Biochim Biophys Acta 1994;1211:23–8.
  52. Bruce C, Chouinard RA, Tall AR. Plasma lipid transfer proteins, high density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998;18:297–330.
  53. Barrans A, Collet X, Barbaras R, et al. Hepatic lipase induces the formation of pre-ß1-high density lipoprotein (HDL) from triacylglycerol-rich HDL2. J Biol Chem 1994;269:11572–7.
Received for publication March 16, 2000. Accepted for publication April 5, 2001.


作者: Maria Teresa Montoya
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具